Literature DB >> 18636184

Pathological complete response induced by the combination therapy of S-1 and 24-h infusion of cisplatin in two cases initially diagnosed as inoperable advanced gastric cancer.

Kenji Ina1, Takae Kataoka, Yuuki Takeuchi, Tomoki Fukuoka, Takaya Miwa, Tomoko Nishio, Ryuichi Furuta, Ayako Masaki, Fumiko Mori, Satoshi Kayukawa, Seiji Nagao, Takafumi Ando, Hidemi Goto.   

Abstract

We report on two patients, successfully treated by the combination therapy of S-1 and 24-h infusion of cisplatin (CDDP), who were initially diagnosed with unresectable stage 4 advanced gastric cancer. Each patient had a very good clinical response and underwent curative gastrectomy after completion of 14 and 10 courses of S-1/CDDP chemotherapy, respectively. A microscopically detailed examination of surgically obtained specimens showed the complete disappearance of malignant cells in the two cases. S-1/CDDP combination therapy can, therefore, be highly active in incurable advanced gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636184

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy.

Authors:  Kenji Ina; Ryuichi Furuta; Takae Kataoka; Satoshi Kayukawa; Takashi Yoshida; Takaya Miwa; Yoshitaka Yamamura; Yuuki Takeuchi
Journal:  World J Clin Oncol       Date:  2011-10-10

2.  Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases.

Authors:  Kenji Ina; Ryuichi Furuta; Takae Kataoka; Satoshi Kayukawa; Hiroko Ina; Masahiko Yoneda
Journal:  Med Sci (Basel)       Date:  2016-04-07

Review 3.  The use of lentinan for treating gastric cancer.

Authors:  Kenji Ina; Takae Kataoka; Takafumi Ando
Journal:  Anticancer Agents Med Chem       Date:  2013-06       Impact factor: 2.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.